IPM
Desconocido
MATURE-NK: MAnufacturing of TUmour REactive Natural Killer cells
INNATE PHARMA
participó en un
H2020:
H2020-MSCA-ITN-2017
"This project will provide future-oriented translational research training designed to bridge the gap between basic research and applied dev...
2018-05-18 - 2022-11-30 | Financiado
2018-05-18 - 2022-11-30 | Financiado
TUMADOR: Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosupp...
INNATE PHARMA
participó en un
FP7:
Studies have demonstrated the importance of CD73 in the spread of cancer. Overexpressed in numerous cancer types, this enzyme leads to the p...
Financiado
Financiado
* No se disponen de datos de la empresa actual.